X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (73) 73
life sciences & biomedicine (71) 71
humans (60) 60
antithrombotic therapy (36) 36
anticoagulants (33) 33
risk factors (31) 31
fibrinolytic agents - therapeutic use (29) 29
fibrinolytic agents - adverse effects (27) 27
evidence-based medicine (25) 25
general & internal medicine (25) 25
abridged index medicus (24) 24
antithrombotic therapy and prevention of thrombosis, 9th ed (24) 24
critical care medicine (24) 24
respiratory system (24) 24
societies, medical (24) 24
thromboembolism (24) 24
female (23) 23
male (22) 22
thrombosis - drug therapy (22) 22
american college of chest physician evidence-based clinical practice guidelines online only (21) 21
antithrombotic therapy and prevention of thrombosis, 9th ed: american college of chest physician evidence-based clinical practice guidelines online only articles (21) 21
thrombosis (21) 21
medicine & public health (20) 20
aged (19) 19
anticoagulants - adverse effects (19) 19
cardiovascular system & cardiology (19) 19
anticoagulants - therapeutic use (18) 18
bleeding (18) 18
hemorrhage - chemically induced (17) 17
thrombosis - prevention & control (17) 17
united states (17) 17
cardiac & cardiovascular systems (15) 15
middle aged (14) 14
prevention (14) 14
stroke (14) 14
antithrombotic (13) 13
atrial fibrillation (13) 13
platelet aggregation inhibitors - therapeutic use (13) 13
practice guidelines as topic (13) 13
stroke - prevention & control (13) 13
cardiology (12) 12
hematology (12) 12
platelet aggregation inhibitors - adverse effects (12) 12
thrombosis - blood (12) 12
warfarin (12) 12
aspirin (11) 11
dose-response relationship, drug (11) 11
venous thromboembolism (11) 11
analysis (10) 10
atrial fibrillation - drug therapy (10) 10
surgery (10) 10
treatment outcome (10) 10
anticoagulants - administration & dosage (9) 9
atrial fibrillation - complications (9) 9
care and treatment (9) 9
drug therapy (9) 9
drug therapy, combination (9) 9
guidelines (9) 9
health aspects (9) 9
mortality (9) 9
patients (9) 9
peripheral vascular disease (9) 9
administration, oral (8) 8
aged, 80 and over (8) 8
antithrombotics (8) 8
aspirin - therapeutic use (8) 8
drug administration schedule (8) 8
hemorrhage - prevention & control (8) 8
heparin - adverse effects (8) 8
postoperative complications - prevention & control (8) 8
retrospective studies (8) 8
review (8) 8
risk assessment (8) 8
vitamin k - antagonists & inhibitors (8) 8
anticoagulation (7) 7
aspirin - adverse effects (7) 7
cardiac arrhythmia (7) 7
health risk assessment (7) 7
hemorrhage (7) 7
hemorrhage - blood (7) 7
heparin - therapeutic use (7) 7
anticoagulant (6) 6
antithrombotic agents (6) 6
antithrombotic treatment (6) 6
cardiovascular agents (6) 6
combined modality therapy (6) 6
deep vein thrombosis (6) 6
fibrinolytic agents - administration & dosage (6) 6
heparin, low-molecular-weight - adverse effects (6) 6
medical research (6) 6
pulmonary embolism (6) 6
pulmonary embolism - drug therapy (6) 6
randomized controlled trials as topic (6) 6
risk (6) 6
studies (6) 6
thromboembolism - prevention & control (6) 6
thrombolytic drugs (6) 6
time factors (6) 6
venous thromboembolism - drug therapy (6) 6
venous thromboembolism - prevention & control (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e601S - e636S
Objectives: This article provides recommendations on the use of antithrombotic therapy in patients with stroke or transient ischemic attack (TIA). Methods... 
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Recombinant Proteins - therapeutic use | United States | Humans | Heparin - therapeutic use | Tissue Plasminogen Activator - therapeutic use | Intracranial Thrombosis - prevention & control | Recombinant Proteins - adverse effects | Heparin - adverse effects | Tissue Plasminogen Activator - adverse effects | Dose-Response Relationship, Drug | Fibrinolytic Agents - adverse effects | Societies, Medical | Aspirin - adverse effects | Fibrinolytic Agents - therapeutic use | Ischemic Attack, Transient - etiology | Aspirin - therapeutic use | Intracranial Thrombosis - drug therapy | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Stroke - prevention & control | Ischemic Attack, Transient - drug therapy | Intermittent Pneumatic Compression Devices | Intracranial Thrombosis - blood | Combined Modality Therapy | Stroke - drug therapy | Evidence-Based Medicine | Stroke - blood | Intracranial Thrombosis - etiology | Thrombolytic Therapy | Ischemic Attack, Transient - blood | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e278S - e325S
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e326S - e350S
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 141, Issue 2, pp. e44S - e88S
Background: The objective of this article is to summarize the published literature concerning the pharmacokinetics and pharmacodynamics of oral anticoagulant... 
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | United States | Humans | Pyridines - pharmacokinetics | Antithrombins - administration & dosage | Thiophenes - administration & dosage | Dabigatran | Antithrombins - pharmacokinetics | Dose-Response Relationship, Drug | Rivaroxaban | Pyridines - adverse effects | Vitamin K - antagonists & inhibitors | Societies, Medical | Benzimidazoles - administration & dosage | Thrombosis - blood | Thrombosis - prevention & control | Benzimidazoles - adverse effects | Morpholines - adverse effects | Pyridines - administration & dosage | Administration, Oral | Morpholines - administration & dosage | Benzimidazoles - pharmacokinetics | Anticoagulants - adverse effects | Evidence-Based Medicine | Factor Xa - metabolism | Thiophenes - pharmacokinetics | Vitamin K - blood | Antithrombins - adverse effects | Anticoagulants - pharmacokinetics | Thrombosis - drug therapy | Morpholines - pharmacokinetics | Practice Guidelines as Topic | Index Medicus | Abridged Index Medicus | Antithrombotic Therapy and Prevention of Thrombosis, 9th Ed | American College of Chest Physician Evidence-Based Clinical Practice Guidelines Online Only
Journal Article